ReviewTranslational neurodegeneration2025

Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives.

Byeong-Hyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.